Pathology of thrombotic thrombocytopenic purpura in the placenta, with emphasis on the "snowman sign"

Pediatric and Developmental Pathology

Volumn 10, Issue 6, 2007, Pages 455-462

  Jamshed, Saad ^a   Kouides, Peter ^a   Sham, Ronald ^a   Cramer, Stewart ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

ADAMTS 13; Placenta; Plasmapheresis; Spiral arteries; Thrombotic thrombocytopenic purpura

Indexed keywords

HYALIN;

ADULT; ANEURYSM; ARTICLE; CASE REPORT; DECISION MAKING; DIFFERENTIAL DIAGNOSIS; FEMALE; FETUS WASTAGE; HUMAN; LABORATORY TEST; MEDICAL LITERATURE; PATHOLOGY; PLACENTA; PLASMAPHERESIS; PREGNANCY; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TROPHOBLAST;

ADAM PROTEINS; ADULT; ARTERIES; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION, MALIGNANT; PLACENTA; PLACENTA DISEASES; PLASMA EXCHANGE; PLASMAPHERESIS; PRE-ECLAMPSIA; PREDNISONE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PURPURA, THROMBOCYTOPENIC; PURPURA, THROMBOTIC THROMBOCYTOPENIC; TREATMENT OUTCOME;

EID: 37349087453     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/07-01-0206.1     Document Type: Article

References (33)

1. Moschcovitz E. Hyaline thrombosis of the terminal arterioles and capillaries - a hitherto undescribed disease. Proc NY Pathol Soc 1924;24:21-24.
2. Carter JR. Generalized arteriolar and capillary thrombosis. Am J Med Science 1947;213:585-592.
3. Gore I. Disseminated arteriolar and capillary platelet thrombosis. Am J Pathol 1950;26:155-167.
4. Orbison JL. Morphology of thrombotic thrombocytopenic purpura, with demonstration of aneurysms. Am J Pathol 1952;28:129-135.
5. Feldman J, Mardiney MR, Unanue ER, Cutting H. The vascular pathology of thrombotic thrombocytopenic purpura. Lab Invest 1966;15:927-946.
6. Kouides PA, Phatak PD, Cramer SF. Fatal thrombotic thrombocytopenic purpura presenting concurrently with metastatic multiple endocrine neoplasia type I. Hematopathol Molec Hematol 1996;10:161-170.
7. Veyradier A, Meyer D. Thrombotic thrombocytopenic purpura and its diagnosis. J Thromb Haemost 2005;3:2420-2427.
8. Wurzel JM. TTP lesions in placenta but not fetus (Letter). N Engl J Med 1979;301:503-504.
9. Koyama T, Oura Y, Kakishita E, Nagai K, Matsuda T, Isojima S. Successful delivery in a female with thrombotic thrombocytopenic purpura. Jpn J Med 1987;26:381-384.
10. Rozdzinski E, Hertenstein B, Schmesier T, Seifried E, Kurrle E, Heimpel H. Thrombotic thrombocytopenic purpura in early pregnancy with maternal and fetal survival. Ann Hematol 1992;64:245-248.
11. Kemp WL, Barnard JJ, Prahlow JA. Death due to TTP in pregnancy: a case report with review of thrombotic angiopathies of pregnancy. Am J Forensic Med Pathol 1999;20:189-198.
12. Symmers WC. Thrombotic microangiopathy - histologic diagnosis during life. Lancet 1956;270:592-597.
13. Prahlow JA, Barnard JJ. Pregnancy-related maternal deaths. Am J Forensic Med Pathol 2004;25:220-236.
14. Veyradier A, Obert B, Houllier A, Meyer D, Girma J-P. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies - a study of 111 cases. Blood 2001;98:1765-1772.
15. Koenig M, Roy M, Baccot S, Cuilleron M, de Filippis JP, Cathebras P. Thrombotic microangiopathy with liver, gut, and bone infarction (catastrophic antiphospholipid syndrome) associated with HELLP syndrome. Clin Rheumatol 2005;24:166-168.
16. Cervera R, Asherton RA. Catastrophic antiphospholipid syndrome - review. Pathophysiol Haemost Thromb 2006;35:181-186.
17. Gilbert-Barness E, Debich-Spicer D. Cardiovascular System. In: E Gilbert-Barness, ed. Potter's Pathology of the Fetus and Infant. St Louis: Mosby, 1997;704.
18. Kraus FT, Redline RW, Gersell DJ, et al. Placental Pathology. Washington, DC: Armed Forces Institute of Pathology, Nontumor Fascicle 3; 2004:14-15,33-34,122-123.
19. Faye-Petersen OM, Heller DS, Joshi VV. Handbook of Placental Pathology, 2nd ed. New York: Taylor and Francis, 2006:75-77.
20. Gerritsen HE, Turecek PL, Schwarz HP, Lammie B, Furlan M. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF. Thromb Haemost 1999;82:1386-1389.
21. Schulman I, Pierce M, Lukens A, Currimbhoy Z. Studies on thrombopoiesis - a factor in normal human plasma required for platelet production: chronic thrombocytopenia due to its deficiency. Blood 1960;16:943-957.
22. Upshaw JD. Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia. N Engl J Med 1978;298:1350-1352.
23. Levy GC, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001;413:488-494.
24. Kokame K, Miyata T. Genetic defects leading to hereditary thrombotic thrombocytopenic purpura. Semin Hematol 2004;41:34-40.
25. Bianchi V, Robles R, Alberio L, Furlan M, Lammie B. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders - a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood 2002;100:710-713.
26. Hebisch G, Bernascomi MT, Gmuer J, Huch A, Stallmach T. Pregnancy-associated recurrent hemolytic uremic syndrome with fetal thrombotic vasculopathy in the placenta. Am J Obstet Gynecol 2001;185:1265-1266.
27. Redline RW. Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy. Human Pathol 2004;35:1494-1498.
28. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.
29. Sibai BM. Thrombophilias and adverse outcomes of pregnancy - what should a clinician do (editorial)? N Engl J Med 1999;340:50-51.
30. Vern TZ, Alles AJ, Roberts DJ, Kowal-Vern A, Longtine J. Frequency of factor V(Leiden) and prothrombin G20210A in placentas and their relationship with placental lesions. Hum Pathol 2000;31:1036-1043.
31. Martin JN Jr, Files JC, Blake PG, et al. Plasma exchange for preeclampsia: postpartum use for persistently severe preeclampsiaeclampsia with HELLP syndrome. Am J Obstet Gynecol 1990;162:126-137.
32. Katz VL, Watson WJ, Thorp JM Jr, Hansen W, Bowes WA Jr. Treatment of persistent postpartum HELLP syndrome with plasmapheresis. Am J Perinatal 1992;9:120-122.
33. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-1006.